截至月份: 2025年9月30日 狀態: 新提交 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 致：香港交易及結算所有限公司 公司名稱: 优趣汇控股有限公司 呈交日期: 2025年10月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02177 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 3,800,000,000 | HKD | | 0.0001 | HKD | | 380,000 | | 增加 / 減少 (-) | | | 0 | | | | HKD | | 0 | | 本月底結存 | | | 3,800,000,000 | HKD | | 0.0001 | HKD | | 380,000 | 本月底法定/註冊 ...

（於開曼群島註冊成立的有限公司） (Stock Code 股份代號: 2177) Dear non-registered shareholder(s), 26 September 2025 Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications With reference to the notification letter dated 21 August 2024 titled "Arrangement of Electronic Dissemination of Corporate Communications", UNQ Holdings Limited (the "Company") is writing to remind you that the Company has adopted electronic dissemination of corporate communications (the "Corporate Communications"), ...

(Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限公司） (Stock Code 股份代號: 2177) Dear registered shareholder(s), 26 September 2025 Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications (Note 1) Solicitation of electronic contact details With reference to the notification letter dated 21 August 2024 titled "Arrangement of Electronic Dissemination of Corporate Communications", UNQ Holdings Limited (the "Company") is writing to remind you that the ...

(incorporated in the Cayman Islands with limited liability) ( 於開曼群島註冊成立的有限公司) Stock Code 股份代號 : 2 1 7 7 INTERIM REPORT 2025 中期報告 2025 INTERIM REPORT 中期報告 目錄 | 2 | 公司簡介 | | --- | --- | | 3 | 公司資料 | | 5 | 財務摘要 | | 6 | 管理層討論與分析 | | 15 | 其他資料 | | 22 | 中期簡明綜合全面收入表 | | 24 | 中期簡明綜合資產負債表 | | 26 | 中期簡明綜合權益變動表 | | 27 | 中期簡明綜合現金流量表 | | 28 | 中期簡明綜合財務資料附註 | 公司簡介 優趣匯控股有限公司（「本公司」或「我們」，連同其附屬公司為「本集團」）是中國領先的品牌電子商務運營服務商，專 注於快速消費品，包括成人個人護理產品、嬰幼兒個人護理產品、美妝產品、健康產品及其他等產品品類。我們與 包括尤妮佳集團蘇菲、moony等品牌，菲婷絲集團品牌包括水之密語、可悠然、惠潤、FINO等品牌，高絲集團Ko ...

Core Insights - Vanpearl, a Canadian health food brand under Youquhui, achieved total sales exceeding 4 million yuan and sold over 8,000 bottles during the Singapore traceability event held from September 7 to 9 [1][2] - The ERGO-VITALIS gene capsule, Vanpearl's core product, features a patented formula designed to repair DNA and delay aging, enhancing cellular self-repair and metabolic efficiency [1] - The collaboration with "Molecular Lab" not only resulted in high traffic and conversion rates but also strengthened Vanpearl's brand influence in the premium health supplement market [1] Sales Performance - Total sales during the event surpassed 4 million yuan, with over 8,000 bottles sold [1][2] - The product ranked first on Douyin's health food sales chart during the live broadcast on September 7 [1][2] Product Innovation - The ERGO-VITALIS gene capsule incorporates cutting-edge research and innovative ingredients aimed at DNA repair and anti-aging [1] - The product is described as a "gene guardian," focusing on enhancing the stability of the DNA genome and improving cellular repair efficiency [1] Brand Strategy - Youquhui leverages its capabilities in supply chain management, brand operation, and cross-border e-commerce to connect its own brands with international research resources [1]

智通财经APP获悉，9月7日至9日，优趣汇(02177)旗下加拿大保健食品Vanpearl携手"大分子实验室"开启 新加坡溯源专场再传捷报，实现总销售额突破400万元，销售数量超过8000瓶(1)，并在7日首发场持续 霸榜抖音保健食品带货榜TOP1，直播间流量与转化表现超高(2)。 备注： Vanpearl作为优趣汇重点孵化的加拿大保健食品品牌，其核心产品ERGO - VITALIS™基因胶囊，凝聚了 前沿科研智慧与创新成分，产品蕴含着修复DNA延缓衰老的专利配方，它能精准激活细胞本源的生命 因子，有效替换受损DNA基因片段，同时全方位保护DNA基因组稳定，从根本上提升细胞自我修复效 率与代谢效率，实现细胞DNA基因层面的抗衰老效果，堪称 "基因守护者"。 此次Vanpearl与大分子合作的新加坡溯源专场，不仅实现了流量与转化的双高表现，也进一步巩固了其 在高端保健品市场的品牌影响力。优趣汇也凭借着在供应链、品牌运营与跨境电商领域的整合能力，持 续推动自有品牌与国际科研资源对接。 (1)以上销售及数量数据取自9月7号-9月9号，数据来源于飞瓜 (2)9月7号基因胶囊新加坡研学专场首发8点-9点持续霸榜保健食品 ...

爱弗乐(Alforex)双效益生菌产品，是专门针对肠易激综合征(IBS)的解决方案，融合了经过科学验证的长 双歧杆菌35624™和1714™专研菌株，协同发挥作用。研究证实，它能改善肠道环境，在缓解腹痛、腹 泻、便秘、胀气等肠道不适症状方面表现出显著的效果。同时，它对舒压助眠、调节情绪起着积极的作 用。此外，作为全球知名益生菌，爱弗乐双效益生菌实现肠脑双效，还获得美国&世界肠胃病学组织推 荐。 1.数据来源于第3方飞瓜抖音版平台ALFLOREX双效益生菌在2025年9月8日-2025年9月9日期间的销售金额和销售件数; 2.抖音商品榜TOP1是指ALFLOREX双效益生菌在抖音店铺罗盘-商品榜单，海外膳食营养补充食品类目2025年9月8日 09:30-11:30期间的实时排名; 3.带货总榜TOP3和保健食品带货榜TOP1是指抖音帐号-王囡囡，在2025年9月8日09:30-11:30期间在抖音带货榜总榜和 保健食品榜单的实时排名。 智通财经APP获悉，优趣汇(02177)与普葆™达成战略合作后，旗下爱弗乐(Alforex)双效益生菌于 2025 年 9 月 8 日迎来首发专场，此次首发告捷，销售额突破 40 ...

Group 1 - The event "Big Consumption Investment Summit and 2025 Zhitong Xingyao Autumn Joint Strategy Meeting" was held in Hangzhou, focusing on the theme "New Consumption Species: The Evolution of Hong Kong Stocks" [1] - In 2025, China's consumption market is witnessing a blend of tradition and innovation, with electric vehicle penetration exceeding 47%, smart home sales growing in double digits, and rural consumption growth outpacing urban by 0.8 percentage points [1] - The Hong Kong stock market is becoming a witness to consumer power, with a 100-fold subscription for consumer IPOs in the first half of the year and 71% of new stocks closing higher on their first day [1] Group 2 - The main venue will feature keynote speeches and roundtable discussions on trends, while the sub-venue will showcase opportunities from 30 top companies [2] - Keynote speakers include executives from Tencent, GF Securities, and various leading companies, sharing insights and practical experiences [4] - The sub-venue will host presentations from 30 leading companies, including China Duty Free Group, Maogeping, and others, focusing on their business opportunities [5]

Core Viewpoint - The financial results of Youquhui (02177) for the first half of 2025 show a revenue of 580 million yuan and a net profit of 11.2 million yuan, indicating a "zero growth" appearance. However, excluding non-recurring items and terminated brand collaborations, revenue increased by 2.5% year-on-year, and net profit remained stable. The gross margin improved by 4.6 percentage points to 34.6% [1] Group 1: "Subtraction" Strategy - Youquhui has consistently focused on actively divesting low-margin brands and channels, which has led to improved profitability despite short-term revenue fluctuations. The gross margin has shown a significant upward trend, increasing from 23.9% in 2022 to 34.6% in the first half of 2025 [2] - The company terminated collaborations with low-margin brands in the personal care and beauty sectors, as well as ceased certain stagnant e-commerce operations, which has contributed to the enhancement of its gross margin [2] Group 2: "Addition" Strategy - Youquhui has identified the health sector as a key area for diversification, with a 42.9% revenue growth in its health segment in the first half of 2025. The self-owned brand Vanpearl generated 14 million yuan in revenue, driven by the successful launch of the ERGO-VITALIS capsule [3][4] - The company is expanding its portfolio by introducing new health brands and optimizing product selection strategies, leading to significant sales increases and breakthroughs in B2B channels [4] Group 3: Future Growth Potential - Youquhui's mid-term report indicates a clear long-term growth trajectory, with a focus on overseas expansion, particularly in Southeast Asia and North America. The company plans to enhance brand presence and penetration through localized compliance and collaboration with local KOLs [5][6] - The company has shifted its investment strategy to prioritize acquisitions and partnerships in the health and beauty sectors, signaling a proactive approach to seizing growth opportunities [6]

Core Viewpoint - The financial results of Youquhui (02177) for the first half of 2025 show a revenue of 580 million yuan and a net profit of 11.2 million yuan, indicating a "zero growth" situation. However, excluding non-recurring items and terminated brand collaborations, revenue increased by 2.5% year-on-year, and net profit remained stable. The gross margin improved by 4.6 percentage points to 34.6% [1] Group 1: "Subtraction" Strategy - Youquhui has been actively divesting low-margin brands and channels, which has led to a continuous improvement in profitability. The gross margin has shown a significant upward trend, increasing from 23.9% in 2022 to 34.6% in the first half of 2025 [2] - The company terminated collaborations with low-margin brands in the personal care and beauty sectors, as well as ceased operations in stagnant e-commerce businesses, indicating a strategic shift towards higher-margin products [2] - The rising gross margin trend is a key indicator of potential future improvements in other performance metrics, despite short-term fluctuations in revenue and net profit [2] Group 2: "Addition" Strategy in Health Sector - Youquhui has identified the health sector as a primary area for diversification, capitalizing on the growing demand for functional health foods. The health segment's revenue grew by 42.9% in the first half of 2025, driven by the strong performance of its proprietary brand Vanpearl, which generated 14 million yuan in revenue [3][4] - The successful launch of the ERGO-VITALIS™ capsule, which utilizes ergothioneine as a key ingredient, has validated the company's health product development model [3] - Youquhui is expanding its partnerships with established health brands, enhancing its market presence and brand influence in the health sector [3] Group 3: Future Growth Potential - The company's mid-year report reflects a strategic investment phase, with a clear long-term growth trajectory despite the absence of immediate steep growth in core financial metrics [5] - Youquhui plans to prioritize overseas expansion, particularly in Southeast Asia and North America, utilizing localized compliance and collaboration with local KOLs to enhance brand visibility and market penetration [6] - The company has shifted its funding strategy from seeking investments in technology companies to focusing on acquisitions and strategic partnerships in the health and beauty sectors, indicating a proactive approach to seizing growth opportunities [6]